In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Description

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Conditions

Thromboembolism

Study Overview

Study Details

Study overview

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Condition
Thromboembolism
Intervention / Treatment

-

Contacts and Locations

Little Rock

Univerisity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72205

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    University of Arkansas,

    Sanjeeva Onteddu, MD, PRINCIPAL_INVESTIGATOR, University of Arkansas

    Jonathan A Young, STUDY_DIRECTOR, University of Arkansas

    Study Record Dates

    2026-01-31